VCYT: Total pendapatan perusahaan Veracyte

Veracyte, Inc. generates revenue from complex genomic research used to identify malignant neoplasms of the lungs and thyroid. The company's sales volume confirms this trend, where 0.58 indicates the value of this parameter. Business growth is driven by the expansion of the genetic testing portfolio and insurance coverage. Service efficiency is maintained through strict control over the transportation of biomaterials to laboratories.

Pendapatan lan volume dodolan Veracyte, Inc. (VCYT): kanggo periode 04.07.2022 - 13.11.2026

Rincian analitis perusahaan Veracyte (VCYT)

- kuotasi lan prakiraan analis:

Bagan rega Veracyte Diagnostics|VCYT - Target konsensus

- informasi kapitalisasi pasar:

Nilai pasar Veracyte, Inc.|VCYT - Nilai Total Perusahaan

- indikator nilai buku ekuitas:

Aset Bersih saben Saham Veracyte|VCYT - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku veracyte.com|VCYT - Aset Agregat Perusahaan

- data liabilitas lan likuiditas perusahaan:

Koefisien Total Utang marang Modal Veracyte, Inc.|VCYT - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Veracyte Inc|VCYT - Gunggung utang perusahaan|Utang-utang marang nilai buku Veracyte, Inc.|VCYT - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Veracyte|Rasio cepet veracyte.com

- rincian bathi lan kelipatan pasar:

VCYT - Bathi resik|Bathi mangsa ngarep Veracyte, Inc.|VCYT - Koefisien rega marang bathi|Rasio prakiraan rega marang bathi veracyte.com|VCYT - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Veracyte, Inc.|VCYT - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Veracyte|VCYT - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan veracyte.com|VCYT - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Veracyte, Inc.

- statistik dodolan lan pendapatan perusahaan:

VCYT - Pendapatan perusahaan|Prakiraan pendapatan perusahaan Veracyte Diagnostics|VCYT - Multiplikator P/S|Multiplikator forward rega marang pendapatan Veracyte, Inc.

Ringkesan analisis perusahaan:VCYT (Veracyte Diagnostics)

Veracyte, Inc. (VCYT) generates revenue through the sale of high-tech genomic tests for non-invasive oncology diagnostics, which is directly reflected in the dynamics of the 0.58 metric. Analyzing the company's commercial revenue through daily monitoring of actual sales allows for the identification of business scaling rates and confirms the validity of the asset's current market value, eliminating the risk of investing in an overvalued instrument during a growth slowdown.

Analisis perusahaan pesaing